
This visual helps illustrate the nuances of each type of bagging in specialty pharmacy and what it may mean for your health system.
A 340B expert discusses how to make sure the program is benefiting patients.
Date
August 17, 2021
Listen time: 7 minutes
A key goal of the 340B Drug Pricing Program is to allocate additional revenue to health services for patients in underserved communities, such as free care for uninsured patients, free vaccines, mental health treatment and more. While overall 340B savings is tracked and managed by hospitals, oftentimes it is not delivered back to the hospitals to invest in such programs. Instead, it can be consumed by high billing and operating costs.
In a conversation with Keith Streckenbach of Pharmacy Practice News, Andrew Wilson, vice president, 340B Solutions for McKesson, discusses this one burning question pertaining to 340B: “Have you examined how your actions with the 340B Drug Pricing Program are benefitting your patients?”
Listen to hear what he shared.
This visual helps illustrate the nuances of each type of bagging in specialty pharmacy and what it may mean for your health system.
As strategic partners, our Specialty Pharmacy Enablement experts can help drive improvements across the board.
In a unique, retreat-style setting, health systems leaders had close conversations around best practices, wins, struggles, and solutions.
Discover three key takeaways from a recent C-suite roundtable discussing the benefits and challenges of central fill for health systems.
Our comprehensive and customizable solutions are deliberately designed with real customer challenges in mind.
McKesson’s Prateek Bhatia, VP/GM, Intrafusion, shares insights on the many opportunities health systems have with their infusion service line.
Expert insights on the rapid growth of specialty pharmacy and the importance of strategic integration.
An exclusive introduction to our newest services and solutions designed to help forward-thinking health systems modernize their specialty and infusion strategies.